193 related articles for article (PubMed ID: 37574548)
1. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
[TBL] [Abstract][Full Text] [Related]
2. Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome.
Townsel C; Covault JM; Hussain N; Oncken C; Nold C; Campbell WA
J Matern Fetal Neonatal Med; 2021 Mar; 34(5):670-676. PubMed ID: 31092079
[No Abstract] [Full Text] [Related]
3. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
[TBL] [Abstract][Full Text] [Related]
4. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
[TBL] [Abstract][Full Text] [Related]
5. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
6. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
7. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
9. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
10. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
11. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
Gersch H; Shah D; Chroust A; Bailey B
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
[TBL] [Abstract][Full Text] [Related]
12. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
[TBL] [Abstract][Full Text] [Related]
13. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Clin Chem; 2011 Mar; 57(3):449-58. PubMed ID: 21245372
[TBL] [Abstract][Full Text] [Related]
14. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective Analysis of Methadone and EDDP in Laboring Women and Neonates in Plasma and Dried Blood Spots and Association with Neonatal Abstinence Syndrome.
Metzger IF; Thomas AE; Evrard CA; Jones DR; Masters AR; Haas DM; Haneline LS; Quinney SK
Am J Perinatol; 2021 Jul; 38(9):968-975. PubMed ID: 32052397
[TBL] [Abstract][Full Text] [Related]
17. Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women's Prison Facility, 2016-2019.
Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto TM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE
J Addict Med; 2023 Sep-Oct 01; 17(5):587-591. PubMed ID: 37788614
[TBL] [Abstract][Full Text] [Related]
18. Methadone and metabolites in hair of methadone-assisted pregnant women and their infants.
Himes SK; Goodwin RS; Rock CM; Jones HE; Johnson RE; Wilkins DG; Huestis MA
Ther Drug Monit; 2012 Jun; 34(3):337-44. PubMed ID: 22495425
[TBL] [Abstract][Full Text] [Related]
19. There is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome.
Townsel C; Odukoya E; Rae J; Thomas D
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9227-9233. PubMed ID: 34978244
[TBL] [Abstract][Full Text] [Related]
20. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
